These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 19457511)

  • 1. [Different patterns of homocysteine in patients with peripheral arterial disease].
    Burgos MI; Fenollar M; Avilés F; Parra MS
    Med Clin (Barc); 2010 Apr; 134(10):467-8. PubMed ID: 19457511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
    Iacoviello L; Donati MB; de Gaetano G
    Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral vascular disease and Virchow's triad for thrombogenesis.
    Makin A; Silverman SH; Lip GY
    QJM; 2002 Apr; 95(4):199-210. PubMed ID: 11937646
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
    Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
    Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for progression of peripheral arterial disease in large and small vessels.
    Aboyans V; Criqui MH; Denenberg JO; Knoke JD; Ridker PM; Fronek A
    Circulation; 2006 Jun; 113(22):2623-9. PubMed ID: 16735675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer and inflammatory markers in the peripheral arterial disease.
    Moresco RN; Silla L
    Thromb Res; 2007; 119(6):797-8. PubMed ID: 16949137
    [No Abstract]   [Full Text] [Related]  

  • 7. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel risk factors for peripheral arterial disease in young women.
    Bloemenkamp DG; van den Bosch MA; Mali WP; Tanis BC; Rosendaal FR; Kemmeren JM; Algra A; Visseren FL; van der Graaf Y
    Am J Med; 2002 Oct; 113(6):462-7. PubMed ID: 12427494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CD40 ligand in peripheral arterial disease.
    Moresco RN; de Bem AF; da Silva JE
    Thromb Res; 2007; 120(5):781-2. PubMed ID: 17433826
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
    Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
    J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study.
    McDermott MM; Guralnik JM; Corsi A; Albay M; Macchi C; Bandinelli S; Ferrucci L
    Am Heart J; 2005 Aug; 150(2):276-81. PubMed ID: 16086930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic renal artery stenosis: association with emerging vascular risk factors.
    Paraskevas KI; Hamilton G; Cross JM; Mikhailidis DP
    Nephron Clin Pract; 2008; 108(1):c56-66. PubMed ID: 18097149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-dimer and platelet aggregation and peripheral arterial disease.
    Greenhalgh R
    Eur Heart J; 2002 Aug; 23(16):1241-2. PubMed ID: 12175660
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
    Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
    Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of hyper-homocysteinemia in the etiology of some vascular diseases].
    Czeizel E; Matos L
    Orv Hetil; 1998 Sep; 139(37):2191-6. PubMed ID: 9769688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration.
    Vine AK; Stader J; Branham K; Musch DC; Swaroop A
    Ophthalmology; 2005 Dec; 112(12):2076-80. PubMed ID: 16225921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation status and biochemical and inflammatory markers in multiple sclerosis.
    Aksungar FB; Topkaya AE; Yildiz Z; Sahin S; Turk U
    J Clin Neurosci; 2008 Apr; 15(4):393-7. PubMed ID: 18258432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.